Novocure
NVCR
#5719
Rank
โ‚ฌ1.18 B
Marketcap
Country
10,11ย โ‚ฌ
Share price
-1.42%
Change (1 day)
4.23%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2026 (TTM): -โ‚ฌ77.9 Million

According to Novocure 's latest financial reports the company's current earnings are โ‚ฌ0.72 Billion. In 2025 the company made an earning of -โ‚ฌ0.11 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ77.9 Million-28.02%
2025 -โ‚ฌ0.11 Billion-1.33%
2024 -โ‚ฌ0.11 Billion-35.88%
2023 -โ‚ฌ0.18 Billion139.99%
2022 -โ‚ฌ71.28 Million61.43%
2021 -โ‚ฌ44.16 Million-235.99%
2020 โ‚ฌ32.46 M630.75%
2019 โ‚ฌ4.44 M-115.08%
2018 -โ‚ฌ29.46 Million-15.13%
2017 -โ‚ฌ34.72 Million-66.9%
2016 -โ‚ฌ0.11 Billion10.26%
2015 -โ‚ฌ95.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚ฌ2.26 Million-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚ฌ66.33 Million-18.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚ฌ0.21 Billion 148.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚ฌ81.67 Million 0.00% Jersey